NON-METASTATIC NASOPHARYNGEAL CARCINOMA
Clinical trials for NON-METASTATIC NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-METASTATIC NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-METASTATIC NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored radiation aims to shrink tumors, spare healthy tissue in nasopharyngeal cancer
Disease control Recruiting nowThis phase 3 trial tests whether a personalized radiation plan, which expands the treatment area based on each patient's tumor margins, can control nasopharyngeal cancer as well as the standard approach. The study includes 568 adults with newly diagnosed, non-metastatic disease. …
Matched conditions: NON-METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New risk model may personalize Post-Chemo decisions for nasopharyngeal cancer
Knowledge-focused Recruiting nowThis observational study is testing whether a new tool called RAIRI can better identify which patients with nasopharyngeal cancer might benefit from additional therapy after standard chemoradiation. About 900 adults with non-metastatic disease will be followed to see if the RAIRI…
Matched conditions: NON-METASTATIC NASOPHARYNGEAL CARCINOMA
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC